Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 2697       
ORIGINAL ARTICLE
Year : 2013  |  Volume : 138  |  Issue : 6  |  Page : 866-872

Role of secretory phospholipase A 2 in women with metabolic syndrome


1 University of Medicine & Pharmacy, Department of Internal Medicine; Rehabilitation Hospital,Discipline of Cardiology, Department of Internal Medicine, Cluj-Napoca, Romania
2 University of Medicine & Pharmacy, Department of Internal Medicine; Babes-Bolyai University, Faculty of Economics & Business Administration, Department of Economic Informatics,Cluj-Napoca, Romania
3 Rehabilitation Hospital,Discipline of Cardiology, Department of Internal Medicine, Cluj-Napoca, Romania
4 University of Medicine & Pharmacy, Department of Internal Medicine, Cluj-Napoca, Romania
5 Babes-Bolyai University, Faculty of Economics & Business Administration, Department of Economic Informatics, Romania

Correspondence Address:
D Pop
Bihorului 5 Str, Cluj-Napoca
Romania
L Stanca
Bihorului 5 Str, Cluj-Napoca
Romania
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 24521628

Rights and PermissionsRights and Permissions

Background & objectives: Secretory phospholipase A 2 (sPLA 2 ), a member of the phospholipase A2 superfamily of enzymes that hydrolyses phospholipids, is a potentially useful plasma biomarker for atherosclerotic cardiovascular disease. Cardiovascular diseases are the leading cause of mortality in women. The purpose of this study was to investigate the correlation between cardiovascular risk factors and the sPLA 2 levels in women with metabolic syndrome as compared to women without metabolic syndrome and men with metabolic syndrome. Methods: Patients (n=100) with various cardiovascular risk factors consecutively evaluated at the Rehabilitation Hospital-Cardiology Department, Cluj-Napoca, Romania were enrolled during 2011, of whom 10 were excluded. The patients were divided in three groups: group 1 (37 women with metabolic syndrome), group 2 (27 men with metabolic syndrome), and group 3 (26 women without metabolic syndrome). Body weight, smoking habits, glycaemia, hypertension, and serum lipids fractions were analysed as cardiovascular factors. Serum sPLA 2 activity was measured using the chromogenic method. Results: There were no statistically significant correlations between sPLA 2 levels and the investigated risk factors, irrespective of patient groups. However, there were significant positive correlations between sPLA 2 and hsCRP in all three groups (P<0.05). In women with no metabolic syndrome an negative correlation was found between sPLA 2 levels and HDL-C- r=-0.419, P=0.03. In men with metabolic syndrome there was a direct correlation between sPLA 2 levels and HOMA, r=0.43, P<0.05, 95% CI (-0.098; 1.15). Interpretation & conclusions: Women with metabolic syndrome did not display different sPLA 2 levels as compared to men with metabolic syndrome and women without metabolic syndrome. However, women with metabolic syndrome demonstrated a low but positive correlation between sPLA 2 and hsCRP levels.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed745    
    Printed15    
    Emailed0    
    PDF Downloaded231    
    Comments [Add]    

Recommend this journal